fda bpc-157 warning not approved for human use unapproved new drug The FDA has issued clear signals on BPC-157 bpc-157 fda warning unapproved peptide

A 2026 report covering the first human trial data on Thymosin Beta-4 in cardiac recovery, confirming the biological mechanisms underlying TB-500s application in tissue repair through the same angiogenic and cell migration pathways illustrates why understanding the compounds mechanism matters as much as sourcing it correctly

While human longevity data is still emerging, the mechanistic basis for anti-aging effects is well-established

COAs are property of Blueprint and are not to be used without Blueprint's consent.

Storage: Lyophilised at 20C up to 24 months

May your protocols stay effective, your supplementation stay appropriate, and your results stay consistent.